There were one, five and four studies showing a statistically significant increase in the mRNA expression level of TUBB6, RAB5, and SLC25A22 in brain and CNS cancer tissues, in comparison with normal tissues. The gene discussed is SLC25A22; the disease is central nervous system cancer.